The federal government will stop being the predominant purchaser of Covid-19 vaccines, treatments, and tests at some point this fall. White House Covid-19 Response Team coordinator Dr Ashish Jha said his “hope is that in 2023 you’re going to see commercialization of almost all of these products.”